We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

85 hedge funds and large institutions have $997M invested in Karuna Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

576% more capital invested

Capital invested by funds: $147M → $997M (+$849M)

513% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 8

70% more funds holding

Funds holding: 50 → 85 (+35)

67% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 12

Holders
85
Holders Change
+35
Holders Change %
+70%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
49
Increased
20
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$83.4M
2
FCM
Farallon Capital Management
California
+$26.3M
3
BlackRock
BlackRock
New York
+$15.2M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$12M
5
PAMU
Pictet Asset Management (UK)
United Kingdom
+$10.9M

Top Sellers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
-$11.4M
2
RSCM
Rock Springs Capital Management
Maryland
-$7.9M
3
Sands Capital Management
Sands Capital Management
Virginia
-$6.57M
4
EAM
Eventide Asset Management
Massachusetts
-$3.55M
5
Citadel Advisors
Citadel Advisors
Florida
-$3.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
26
ALPS Advisors
Colorado
$3.95M +$2.3M +52,408 New
AG
27
Artal Group
Luxembourg
$3.77M +$2.19M +50,000 New
Charles Schwab
28
Charles Schwab
California
$3.28M +$496K +11,329 +35%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$3M +$1.23M +28,149 +242%
LGM
30
Logos Global Management
California
$2.99M +$1.74M +39,647 New
EI
31
EAM Investors
California
$2.9M +$1.68M +38,447 New
MS
32
Maven Securities
Jersey
$2.53M +$960K +21,920 +168%
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$2.04M +$1.19M +27,118 New
TD Asset Management
34
TD Asset Management
Ontario, Canada
$2.01M +$167K +3,806 +17%
CCM
35
Copernicus Capital Management
California
$1.96M +$1.14M +26,000 New
MAP
36
Moody Aldrich Partners
Massachusetts
$1.94M +$1.13M +25,804 New
EGI
37
EAM Global Investors
California
$1.79M +$1.04M +23,709 New
N
38
Nuveen
North Carolina
$1.7M +$985K +22,493 New
Goldman Sachs
39
Goldman Sachs
New York
$1.19M +$692K +15,809 New
PCM
40
Pinz Capital Management
New York
$1.18M +$686K +15,660 New
PPA
41
Parametric Portfolio Associates
Washington
$1.14M +$660K +15,071 New
G
42
Gainplan
Michigan
$866K +$504K +11,500 New
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$851K +$494K +11,289 New
Jane Street
44
Jane Street
New York
$804K +$467K +10,673 New
SCM
45
Sio Capital Management
New York
$722K +$420K +9,588 New
MA
46
MYDA Advisors
New York
$678K +$394K +9,000 New
GGHC
47
Gilder Gagnon Howe & Co
New York
$678K +$394K +9,002 New
AllianceBernstein
48
AllianceBernstein
Tennessee
$651K +$378K +8,640 New
SEI Investments
49
SEI Investments
Pennsylvania
$646K +$375K +8,569 New
Morgan Stanley
50
Morgan Stanley
New York
$614K +$271K +6,185 +316%
1
2
3 4

KRTX Hedge Fund Activity: Q4 2019 in Review

85 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q4 2019, worth a combined $997M — up 576% from $147M a quarter earlier.

Buyers outnumbered sellers: 49 funds opened new KRTX positions and 8 closed out — a net gain of 41 holders — while 20 added to existing stakes and 12 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $83.4M. The largest seller was Fidelity International, cutting an estimated $11.4M.

  • 85 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q4 2019, up from 50 in Q3 2019.
  • Funds reported $997M of Karuna Therapeutics, Inc. Common Stock stock for Q4 2019, up 576% quarter-over-quarter.
  • 49 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q4 2019 and 8 closed out, a net change of +41 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock buyer in Q4 2019 was Fidelity Investments, an estimated $83.4M added.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q4 2019 was Fidelity International, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2019.